View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The British Veterinary Dental Association (BVDA) has signed a new agreement with Hill's Pet Nutrition which will provide support for the next three years.
The agreement comes after the previous period of sponsorship between the company and the BVDA reached the end of the three year term.
Lisa Milella, President, signed the agreement on behalf of the BVDA. She said: "Hill's has provided our organisation with invaluable support that will help us to continue to support the teaching needs of vets, undergraduates and nurses. We will also be able to ensure that dentistry is front of mind when thinking about the health and welfare of animals. Hill's has been a pleasure to work with over the last three years and I am very pleased to be renewing our agreement."
Adrian Pratt, Veterinary Affairs Manager at Hill's Pet Nutrition also welcomed the agreement, "Dentistry is an important source of revenue for practices and central to the wellbeing of pets. Both are priority areas where Hill's will be offering support, particularly during the current economic downturn. We are therefore very pleased to be able to confirm our association with the BVDA."
The agreement comes as the BVDA prepares to celebrate its 21st Birthday at BSAVA Congress in April. The satellite day event on the 1st April promises to be a 'must' for anyone interested in veterinary dentistry, with state of the art lectures that will illustrate how far the craft of dentistry has developed in the last 21 years.
The key note lecture, 'Magical MTA!*' will be delivered by Phil Thomson, Registrar at Birmingham Dental School, using a video linked operating microscope to illustrate how this gold standard endodontic treatment can be implemented. Additional lectures include oro-facial tumours, reconstructive surgery, radiotherapy and an active debate is promised on the topic of feline chronic gingivostomatitis. The meeting is open to members and non-members. Further details and registration are available by contacting Lisa Milella on telephone 01923 349690 or at lisa@milella.fsnet.co.uk.
*Mineral Trioxide Aggregate - MTA - a root canal repair material that allows natural healing and repair of dental tissues of otherwise unsalvageable teeth.
Grahame Gardner has introduced the M559, a classically styled tunic, stocked for the first time in bottle green.
The company says that although it has sold numerous ladies tunics in bottle green, this is the first time it has stocked a male tunic in the characteristic veterinary colour.
The M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits.
Simon Ward, Sales Director said: "We are delighted to introduce this new garment to the veterinary market. We are continually reviewing our range in response to customer comments, and felt it was time we stocked a bottle green option, specifically for male members of the veterinary team."
Stocked in sizes from 34" to 50" (chest), the M559 is just one of several new styles introduced in Grahame Gardner's latest brochure. The company is also launching a new men's scrub tunic. The SS3295 has a v style neck, complemented by the v-detail on the sleeves, and contrasting trim available on the neck, sleeve and pocket. Also stocked in bottle green, the company says this tunic is aimed at veterinary professionals who prefer a more relaxed approach to uniforms.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of their new brochure.
Last year, over 1,400 veterinary practices collected more than 6,000 ticks from dogs for the Big Tick Project, contributing to the largest-ever study of tick-borne illnesses in dogs in Britain, if not worldwide.
Now MSD is calling on practices to do the same for cats. The company says that data collected from the contributions will be used in a scientific paper which will help vets make more specific recommendations to cat owners, and help keep their pets safe.
Amanda Melvin, Senior Product Manager for Bravecto said: "We were delighted and rather overwhelmed by the response, support and level of interest in the BTP for dogs from the veterinary profession. We were expecting 100s of ticks to be submitted but they arrived in their 1000s!
"It made us realise that, with the low levels of awareness of the risks of tick-borne disease to both people and animals, there was an even wider issue to be addressed. The risks to cats could not be ignored.
"We have therefore created the BTP for cats and are asking the vets, once again, to show their support by collecting and sending in ticks from their practices. The more samples we receive the better. This way we can help the profession better understand the risks associated with ticks and how best to help cat owners treat their pets."
Those practices that participated in the BTP last year will automatically be registered and will be sent an email with details of this phase of the project. Any practices that did not participate last year and would like to should send their details to vet-support.uk@merck.com.
To support vets in promoting the BTP for cats to their clients MSD Animal Health has designed a range of materials for display in practice and as takeaways for clients. They include a practice waiting room poster and a cat certificate.
Matt has taken over as hospital director from David Walker, who has now moved to the role of referrals managing director in the south of the UK for Linnaeus.
Matt said: “I certainly have some big shoes to fill but working as clinical director alongside David was a great grounding and we work well together.
“Essentially, I was his running mate back then but now I am stepping up to take on the main role, with all the additional responsibilities it entails, and I’m determined to make it my own.
“I know I have the drive, the desire, the clarity of purpose and the dedication to succeed.
"I also know what an incredible operation I have inherited from David.
“One of the key things about Anderson Moores is that every member of the team works together in the same location to support every aspect of a pet’s treatment and recovery, so whatever service they may need is all available under the same roof.”
www.andersonmoores.com/homewww.zeropainphilosophy.com
The intranasal vaccine can be administered to calves from one week old. It reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V).
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life, and claims the vaccine delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. Duration of immunity is 12 weeks for both viruses.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: "Having this early life calf pneumonia vaccine available in single dose vials will give farmers more practical leeway to be able to vaccinate vulnerable young calves from as young as a week of age, rather than delaying administration until a batch of calves are available. We know that early-age protection of young calves through intranasal vaccination can help prevent pneumonia and positively impact a beef or dairy calf’s productive future".
The new single dose vials are supplied in packs of five, complementing the five dose vials already available.
For further information, contact your MSD account manager.
Organised by The Veterinary Edge in association with Simon Guiton of VETcpd, there will be three streams running throughout, with delegates able to gain 14 hours of CPD – or 16 if prepared to skip the tempting two-course lunches.
Speakers include:
Sessions run from 10am to 6pm on the first day (followed by a happy hour in the exhibition) and from 9am to 5.15pm on day two.
A two-day pass for vets costs £285 and a one-day pass £170 plus VAT.
The prices will increase after 31st August.
Passes include access to all three streams, a two-course lunch, other refreshments and the congress handbook, which will include summaries of the sessions.
Accommodation is available at the recently opened Courtyard by Marriott Hotel at Sandy Park; other hotels nearby include a Premier Inn and Holiday Inn Express.
www.theveterinaryedge.com.
RVC researchers say that the VetCompass study is the largest ever carried out into dental disease in cats using veterinary clinical records.
The study investigated a sample of 18,249 cats randomly selected from a study population of 1,255,130 cats in the UK in 2019.
Periodontal disease was recorded in 15.2% of the sample making it the most common disorder.
The cat breeds with the highest annual levels of this diagnosis were Siamese (18.7%), Maine Coon (16.7%) and British Short Hair (15.5%) as well as crossbreeds (15.4%).
The average bodyweight of cats with periodontal disease (5.7kg) was higher than for cats without periodontal disease (5.5kg).
The risk of periodontal disease rose steeply as cats got older, with cats aged 9 to 12 years being 6.7 times more likely to have periodontal disease compared with cats aged under 3 years.
Cats with periodontal disease were much more likely to have a range of other health conditions compared to cats without periodontal disease (x 1.8 risk).
These conditions included cardiac dysrhythmia (x 2.3 risk), ear discharge (x 2.3 risk) and hairball/furball (x 2.3 risk).
The researchers say that these findings suggest that periodontal disease should be acknowledged as a leading health and welfare issue in cats, and highlight the need for greater dental care in cats as they age.
The study was supported by an award from the Kennel Club Charitable Trust and Agria Pet Insurance.
Stronghold Plus contains the same selamectin found in common-or-garden Stronghold, licensed for the treatment of fleas, flea allergic dermatitis, ear mites (Otodectes cynotis), roundworm (Toxocara cati), intestinal hookworms (Ancylostoma tubaeforme), biting lice (Felicola subrostratus), and for the treatment of heartworm disease caused by Dirofilaria immitis.
To that has been added sarolaner, a new acaricide and insecticide which is also effective for five weeks against Ixodes ricinus, Ixodes hexagonus, and for four weeks against Dermacentor reticulatus and Rhipicephalus sanguineus.
Clint Lewis, Executive Vice President and President International Operations, said: "The launch of Stronghold Plus enables Zoetis to offer veterinarians in the European Union a new topical choice that treats the parasites commonly presenting a threat to cats with one convenient monthly dose.
For the first time, we have combined our new, versatile parasiticide sarolaner with the active ingredient in Stronghold, selamectin, resulting in the first approval of sarolaner for use in cats. We see sarolaner as a promising platform for future product lines and lifecycle innovations and are pleased with the positive data that sarolaner and its combination continue to generate in studies.”
Domenico Otranto, Professor of Parasitology at Bari University in Italy, who has reviewed the product data of Stronghold Plus, said: "A number of laboratory and field studies show the efficacy of the single spot-on application of Stronghold Plus for at least one month. Veterinarians in Europe now have a very effective option for the treatment and control of four prominent species of ticks commonly found on cats while maintaining proven efficacy against fleas, GI worms, heartworms, ear mites and lice. Ultimately, pet owners and practitioners have a new tool for improving health and welfare of cats."
Velactis (cabergoline) is a POM marketed by Ceva Animal Health, used in the herd management programme of dairy cows as an aid in abrupt drying-off, by reducing milk production.
The product was authorised through the European Medicines Agency (EMA) in December 2015 and was first sold in the UK in April 2016.
The VMD says it has been made aware of reports of serious adverse events, predominantly occurring in Denmark, involving recumbency (lying down and unable to rise) and some deaths. Most adverse events occurred within 8 to 24 hours following product administration. Anecdotal evidence suggests that hypocalcaemia treatments may be successful in reversing clinical signs.
Ceva has decided to stop further distribution of the product in Europe voluntarily, pending the outcome of further investigations to assess a possible causal link between the product and the adverse events reported.
The VMD, EMA, other agencies throughout Europe and the MAH are working closely to monitor the situation.
The VMD highlights that due to the nature and use of the product there is no risk to human health or consumer safety.
Vets and dairy farmers are strongly encouraged to report any adverse events associated with use of Velactis to the VMD using its online reporting form or directly to Ceva for further investigation by the MAH as necessary.
With Vetscan Imagyst, samples are prepared in-clinic using traditional methods, but submitted digitally, rather than sending physical slides to a laboratory. In this way, results are available in hours, allowing vets to offer same-day diagnosis and treatment.
The company says the new digital cytology application offers fast, accurate reviews of common cytology specimens, such as fine-needle aspirates,
Jamie Brannan, President International Operations, Zoetis said: "Veterinarians have told us that Vetscan Imagyst technology helps them make better informed decisions in a more transparent way for pet owners. With the cytology feature, Vetscan Imagyst will now offer one platform for multiple tests.”
He added: “We are excited to build on the incredible momentum that began with the AI fecal analysis launch. Vetscan Imagyst has been a significant part of the Zoetis portfolio and continues to evolve to meet diagnostic needs in practices around the world. The unique all-in-one technology has added immense value to veterinary clinics, facilitating fast, more accurate results, leading to quicker diagnoses and decisions that ultimately strengthen the bond of trust between veterinarians and their clients.”
For more information, contact your Zoetis representative or visit www.vetscanimagyst.com
Ceva says Adaptil Junior has been proven to reduce night crying and whining by 86%2 and helps puppies to adapt to their new homes and unfamiliar situations in three days3, 4.
According to the company, puppies with Adaptil Junior are also less fearful and anxious during puppy classes, resulting in better long-term socialisation3.
Research carried out by the company found that over 60% of dog owners buy their dogs as puppies, with half of those questioned getting their dogs before they are three months old1.
Abigail King, product manager for Adaptil at Ceva Animal Health said: "Adopting a puppy is an exciting, yet challenging time with puppies facing stressful situations such as separation from their mother, socialisation, staying home alone and experiencing new sights, sounds and noises.
"Adaptil Junior is an effective, natural solution to help comfort newly adopted puppies and facilitate their education while helping them to learn and adapt to their new lives. This, in turn, will ensure that puppies get off to the best start in life, which will help keep rehoming numbers down."
Adaptil Junior comes in the form of a translucent blue collar which fits necks up to 37.5cm in circumference. The collar releases dog appeasing pheromone over a period of four weeks and should be worn continuously.
To support the launch of Adaptil Junior, Ceva Animal Health has introduced a puppy party marketing pack to provide puppy party organisers with the tools they need in order to stage puppy parties.
Produced in collaboration with the leading dog behaviourist, Gwen Bailey, the pack features display materials, webinars, gifts and literature including leaflets, puppy party invites and posters and is available with Adaptil Junior orders.
For more information, visit www.adaptil.com/uk.
References
Fluboral controls gastro-intestinal nematodes including Ascaridia galli (adult stages), Heterakis gallinarum (adult stages) and Capillaria spp. (adult stages) in chickens and Ascaris suum (adult and L4 intestinal stages) in pigs.
Dechra says Fluboral’s formula allows it to mix in drinking water quickly and easily with five seconds of stirring.
Fluboral has a guaranteed 24-hour stability without sedimentation of the suspension after dilution in drinking water and Dechra says there is no risk of inhomogeneous mixing.
Johnny Wells West, key account manager – pig and poultry at Dechra, said: “Fluboral is a welcome addition to our Solustab range of water-soluble products, providing effortless and efficient parasite control in drinking water to enable farmers and producers to start medication quickly and cost-effectively, as and when needed.”
https://www.dechra.co.uk/products/livestock/prescription/fluboral#Fluboral.
It's a subject that will be front of many people's minds following the recent cases of equine flu.
As part of the campaign, MSD has produced a range of veterinary practice support materials to help you engage with owners and yards on the subject of preventative healthcare best practice and compliance.
The range includes shareable social media content, videos, a 'What's Your Risk' practice poster, an online risk assessment tool and a number of downloadable information leaflets. Practices will also be supported through the Keep Britain's Horses Health (KBHH) web page, Facebook page and Twitter.
MSD says there are also planning and evaluation resources to help practices manage an effective campaign.
Vicki Farr, Equine Veterinary Advisor at MSD Animal Health said: "The recent outbreaks of equine flu have rocked the horse-racing world, costing the industry millions and raising important animal welfare issues. Furthermore, they have highlighted the need for good preventative healthcare and, in particular, vaccination.
"HHW will therefore come at a relevant time for horse owners and yards when the impact of equine flu is still at the front of their minds.
"This year HHW will provide vital tools for practices; building on the knowledge and resources we’ve acquired throughout the KBHH campaign and from previous HHWs.
"Our focus is on engaging owners and yards on understanding the risk of disease for their horse, while rewarding them for best practice. We are again providing a wide range of resources for practices to help them create an engaging and successful campaign that helps build knowledge amongst the equine community."
For further information, talk to your MSD Animal Health Equine Account Manager, call 01908 685685 or refer to KBHH social media feeds on Facebook page and Twitter (@keepinghorseshealthy).
Described as a first-of-its-kind, mobile-enabled digital whitepaper, the publication offers veterinary surgeons and farmers a resource on ketosis, scientific insights on the impact of the disease, and tools to help optimize dairy herd management.
According to the company, the whitepaper reveals that ketone bodies play a more significant role in metabolic diseases than was previously realized, and that beta-hydroxybutyrate is a good indicator of the presence of subclinical ketosis in dairy cattle.
Rinse Boersma, Dairy Species Manager, Animal Health, Bayer said: "Recognizing the significance of ketone bodies is a positive step towards further enhancing dairy cattle health and welfare. Veterinarians can now reliably detect the presence of subclinical ketosis in dairy herds with a simple blood test, and act quickly with the appropriate corrective measures to arrest disease progression."
Also at Congress, Bayer revealed its enhanced BCS Cowdition smartphone application, designed to support ease and accuracy of body condition scoring (BCS) of dairy cows. Bayer says the upgrade helps farmers to improve herd health management by enabling assessment of individual cows’ BCS scores based on its lactation cycle, alerts for cows that need to be attended to, and a dashboard that offers farmers an overview of their entire herd’s health.
BCS Cowdition is available in 10 languages and is free for download from the AppStore and GooglePlay.
The CAMadvocate course (http://www.cameducation.co.uk), which is delivered online, consists of 10 modules with video presentations, course notes, downloads, owner-focused tools, further online learning, and social media uploads.
The course is designed to help canine professionals improve their understanding of canine arthritis, and to define their role in the identification, diagnosis, and management of the condition.
Hannah Capon MRCVS, the founder of Canine Arthritis Management said: "Dog walkers, groomers, trainers, kennel owners, etc., are all influencers! They have the ability to support a long-term veterinary-derived management plan. Or they have the ability to destabilise it!
"Owners listen to these people because they have more available time; they may appear less like a business and more like a friendly service or even a peer; or they may offer advice that seems more convincing. Whatever the reason, we should harness their powers and ensure they are disseminating reliable information whilst servicing their own needs!"
Canine Arthritis Management believes that a multidisciplinary team is required to better manage this disease, that this includes professionals outside the veterinary practice, and by harnessing their influence, the profession can educate more owners, identify this disease earlier, action appropriate management plans and give owners more years with their pets.
Hannah added: "I hope the profession will support this initiative and consider applying it to other chronic diseases that are prone to misinformation due to lucrative product sales."
CommentA training course / qualification developed by a veterinary surgeon and designed to educate influencers. It's genius. Surely there's huge scope for this kind of initiative beyond canine arthritis? What do you think pet owners are most ill-informed about, where it could be really effective to better educate canine influencers, so that they in turn will pass it on. Post your thoughts here.
Hill's Pet Nutrition has highlighted recent studies which, the company says, prove that feeding a food enriched with omega-3 fatty acids from fish oils to dogs with osteoarthritis results in a reduction in NSAID dosage of up to 25%1, owner observed improvements in clinical signs3, and improved weight bearing ability2, 7
The claim that food can effectively support medical treatment follows in the wake of two published and one in press study in the Journal of the American Veterinary Medicine Association (JAVMA). These demonstrate that omega-3 enriched food (in this case Hill's Prescription Diet j/d Canine) has significant effects on weight bearing and helps reduce NSAID dosage by up to 25 per cent, when fed to dogs with osteoarthritis 1, 2,3.
According to Hill's, the research demonstrates that in dogs the high levels of eicosapentaenoic acid (EPA) from fish oils can down-regulate the cartilage degrading enzyme aggrecanase1. In vitro studies have also identified that EPA resulted in a reduction in the amount of degraded cartilage residue produced4. High levels of omega-3 fatty acids can also help to reduce inflammation5,6.
The two studies that were recently published confirm that feeding a diet rich in omega-3 fatty acids aids in the management of osteoarthritis in dogs2,3. The randomized double-blinded controlled trials were carried out over three and six months respectively and involved a total of 165 dogs identified as suffering from mild to moderate osteoarthritis. After collating the results from almost 25,000 trial days, researchers were able to confirm a significant 'clinical improvement' from feeding a food fortified with fatty acids.
In the first study described in JAVMA, researchers found evidence that omega-3 fatty acids from fish oils resulted in improvements in weight bearing2. Objective measurement using force plate gait analysis demonstrated that dogs fed a test food fortified with fatty acids were seven times as likely to show improved weight bearing compared with dogs fed a control food.
In the second study, through a detailed questionnaire, owners also observed significant improvements in their dog's osteoarthritic condition3. Improvements observed covered the following signs: difficulty in rising from rest, limping, stiffness, soreness when touched, yelping or whimpering in pain, aggression, lagging on walks, reluctance to play and overall activity level.
Adrian Pratt, Veterinary Affairs Manager for Hill's Pet Nutrition, manufacturer of Prescription Diet j/d, which is enriched with omega-3 fatty acids, hailed the results as a breakthrough in the field of nutrigenomics (the study of the effects of nutrition on gene expression): "This research points the way to a new model for the management of osteoarthritis, using a clinically proven food to interrupt the cycle of damage and cartilage degradation, alongside graded levels of NSAIDs and proactive programmes to manage weight and adjust exercise routines. Clinicians now have the conclusive proof they need to recommend feeding omega-3 enriched food to ameliorate the signs of osteoarthritis in clients' pets and to adjust NSAID doses accordingly."
For further information on Hill's Prescription Diet j/d, please contact your Hill's Territory Manager or call 0800 282438.
References1. A multicenter study of the effect of a therapeutic food supplemented with fish oil omega-3 fatty acids on the Carpofen dosage in dogs with osteoarthritis. Fritsch A, Allen T, Dodd C, JAVMA in press2. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs. Roush J, Cross A, Renberg W, Dodd C, Sixby K, Fritsch A, Allen T, Jewell, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp67-733. Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Roush J, Dodd C, Fritsch A, Allen T, Jewell D, Schoenherr W, Richardson D, Leventhal P, Hahn K, JAVMA Vol 236 No 1, Jan 2010 pp 59-664. Eicosapentaenoate supplementation abrogates canine articular cartilage degeneration in in vitro explant culture systems, Caterson B, Cramp J, Little C B et al, Hills European Symposium on osteoarthritis and joint health 2005 14-195. Dietary modification of inflammation with lipids, P C Calder, Proceedings of the Nutrition Society 2002 345-3586. Dietary polyunsaturated fatty acids and inflammatory mediator production, James M J, Cleland L G, Gibson R A, Am J Clin Nut 2000: 71 suppl 343S- 358S7. Vasseur PB, Johnson AL, Budsberg SC, et al. Randomized, controlled trial of the efficacy of carprofen, a nonsteroidal anti-inflammatory drug, in the treatment of osteoarthritis in dogs. J Am Vet Med Assoc 1995; 206 (6): 807-811.
The University of Liverpool's School of Veterinary Science has announced the introduction of a new curriculum designed to enhance undergraduate veterinary teaching and learning.
The University says that the curriculum, which was developed in consultation with staff, current and past students, and other key stakeholders, will provide world-leading clinical training, underpinned with the latest scientific knowledge.
The review also explored new ways of teaching in order to reduce the number of lectures in favour of more dynamic forms of training, such as 'scenario' sessions where students work in groups to tackle clinical problems.
Dr Alex German, programme director for the new curriculum, said: "Instead of a modular format, where subjects are taught in self-contained units, we now integrate subjects throughout the degree programme so that students can seamlessly connect what they have learnt to what they are practising.
"Pre-clinical subjects are taught early on, but then revisited during the later stages of the course to ensure that clinical knowledge is based on sound physiological and pathophysiological principles."
Fundamental research skills, such as basic statistics and scientific writing, are taught in the early years, and then reinforced when students undertake a full honours-degree-equivalent research project in their third year.
Evidence-based veterinary medicine principles also underpin all clinical subjects, enabling undergraduates to review clinical evidence critically, and appraise new data as it emerges.
The most significant changes, however, focus on the teaching of clinical skills, which is now taught throughout the five-year programme. To support this, the School has appointed a number of new lecturers specifically to teach clinical skills, and opened new purpose-built teaching laboratories.
Teaching includes the use of models such as a cattle obstetric simulator, a life-size model of a horse with foam pads for practising injections, and a 'Lambinator' for lambing practise. Many of the models have been designed and built by the new lecturers.
A 'cow laboratory' has also been developed to provide an area for self-directed teaching where students can practise skills such as, haltering and casting a cow, learning how to cast a calf's leg, and perform rectal examination with the use of 'Betsy', the in-house reproductive tract simulator (pictured right).
Alison Reid, clinical skills lecturer, said: "When I qualified ten years ago, I could not confidently perform some of the skills we are now teaching our first year students and I remember how unnerving that was when I first entered practice.
"If we can take away the difficulty associated with performing unfamiliar manual skills under pressure, we will be improving the lives of our graduates, their colleagues and their patients."
The diffuser contains a blend of rose, lavender, and chamomile oils, which the company claims provides stress-relieving benefits during car journeys.
'On The Move' is part of the Calmex range, which includes a plug-in diffuser for the home and two nutraceuticals: a palatable tablet for dogs and a liquid formulation for cats.
Jackie Marshall, Technical Advisor at VetPlus, said: “We’re committed to developing products and solutions that allow vets to give their clients the best management options possible to ensure that pets are happy and healthy all year round.
“Combining the new in-car diffuser with the Calmex supplement and plug-in diffuser can be highly effective at supporting animals affected by many causes of stress, including loud noises, separation related anxiety, car travel, and environmental change.
"This gives vets the ability to recommend a truly multimodal approach to help animals cope better with stressful situations both in the home and on the move.
“The products can be used all year round to offer calming support for potentially distressing situations such as visits to the groomer, training and visits to the vet, as well as in the lead up to potentially stressful or busy events like Christmas or New Year’s Eve.”
VetPlus has also worked with behaviourists to develop a free app called Plasid.
Calmex users can access the app, which includes tracking tools, videos from behaviourists, and calming music to help stressed pets, by scanning the QR code on the product packaging.
www.vetplus.co.uk/product-category/brain-behaviour
Zoetis has launched Suvaxyn Parvo/E, a combined vaccine which it says provides the earliest protection of gilts against parvovirus and erysipelas.
Parvovirus and erysipelas infections occur primarily in gilts and sows, negatively impacting their reproductive success and the health of their litters - inevitably reducing profitability.
Nigel Lodge, National Veterinary Manager for Zoetis, said: "The combined vaccine will help ensure the health of gilts and sows is not affected by these two infections which are widespread in the pig herd.
"Suvaxyn® Parvo/E gives the earliest protection so that the ability to vaccinate gilts at five months of age will help ensure a good start to their reproductive life. Up to half of all pigs may be carriers of erysipelas and importantly the vaccine has licensed efficacy against both Erysipelothrix serotypes 1 and 2.
"This brings another vaccine to our portfolio, making it one of the largest in the pig sector and confirming the ongoing commitment of Zoetis to the health and welfare of pigs."
Suvaxyn® Parvo/E is an inactivated combination vaccine approved for immunising gilts and sows to prevent reproductive disorders caused by porcine parvovirus and reduce clinical signs caused by Erysipelothrix rhusiopathiae.
Primary vaccination is recommended from five months of age, with two injections given three to four weeks apart, ensuring the second dose occurs at least four weeks before mating. Revaccination should take place three to four weeks before each subsequent mating.
The vaccine comes in 10-dose and 2 X 25-dose packs. For more information, contact your Zoetis Pig Key Account Manager.
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his practice’s equipment and facilities in working order and for a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on 20th May was Mr Seymour-Hamilton’s seventh application for restoration. Previous applications had been heard but refused in July 1995, June 2010, February 2015, March 2016, May 2017 and April 2018. However, as the Committee makes its decision on the merits of the case before it, those previous applications were not considered as relevant to its current decision.
The Committee heard oral evidence from Mr Seymour-Hamilton and were shown clear bottles with liquid, a container with tablets and petri dishes with grown cultures as detailed documentary evidence. In respect of any concerns regarding keeping his veterinary practice up-to-date, Mr Seymour-Hamilton said that “you never lose that skill” and explained that he kept up-to-date through extensive reading and conversations with veterinary surgeons in Europe.
However, the Committee had significant concerns as to his fitness to practise safely as a veterinary surgeon for a number of reasons, including that nearly 25 years had passed since he was last in practice and that there was little, if any, evidence of him keeping up-to-date with the knowledge and skills required to practise as a veterinary surgeon.
Ian Green, chairing the Committee and speaking on its behalf, said: "The applicant worryingly did not accept that he was in any way deskilled by the passage of time. The evidence that the applicant has provided showed limited interaction with other veterinary surgeons and there is no documented evidence of the discussions or structure of the meetings he had with veterinary surgeons in Europe.
"There is no evidence of a prolonged and intense period of re-training by way of relevant study to demonstrate that a sufficient level of competence to return to practise has been achieved. In the absence of such evidence the Committee was of the view that there would be a serious risk to the welfare of animals if the applicant was restored to the Register.
"Further, it was a grave concern to this Committee that the applicant demonstrated worrying attitudinal issues towards individuals of a different religion and his attitude to employing a minor when he knew it to be against the law. Such attitudes are incompatible with professional standards the public would expect of a veterinary surgeon."
Finally, with no evidence of public support for the applicant, the Committee concluded that the application for restoration should be refused.
Intervet/Schering-Plough Animal Health has announced the launch of Nuflor Minidose - a 50% more concentrated, but less viscous solution of its proven Nuflor antibiotic.
Nuflor Minidose is licensed for the treatment and prevention of bacterial BRD. Intervet/Schering-Plough Animal Health livestock veterinary adviser Rosemary Booth MRCVS said: "It delivers all the rapid efficacy entrusted in Nuflor, but at a lower volume. Whereas a 20ml dose of Nuflor will treat a 150kg animal, the same volume of Nuflor Minidose will cover a 225kg beast. Compared with Nuflor, the new Minidose formulation is easier to administer delivering a less viscous florfenicol solution, with a 62% improvement in viscosity at 15°C and 59% at 5°C."
Rosemary added that Nuflor Minidose is effective against the main bacterial causes of pneumonia: P. multocida, M. haemolytica and H. somni. "Florfenicol is the only antibiotic offering 100% sensitivity to these three key BRD causes in recent trials and its kill effect also ensures that within 24 hours bacteria levels are low enough to prevent any re-growth."
She also pointed out that the new, more concentrated florfenicol solution presents vets with an improved batch treatment option for controlling BRD considering Nuflor is recognised as an effective metaphylactic
"Batch treatment prevents BRD from spreading. Trials with Nuflor have demonstrated the benefit of metaphylactic batch treatment of sick calves in a pen once at least 20% of the animals exhibit disease symptoms. Nuflor was significantly more efficacious than a control in preventing the spread of BRD in healthy calves exposed to infected animals," she explains.
"The bacteria responsible for BRD are found in the respiratory tract of healthy cattle and stress or a greater pathogen load - such as exposure to sick calves - can easily trigger disease. BRD bacterial numbers can double every 30 minutes and in 24 hours, one bacterium can multiply to billions. Batch treatment kills the bacteria before they multiply, release toxins and cause permanent lung damage."
New Nuflor Minidose is licensed for injection subcutaneously for the prevention of BRD at a dose rate of 4ml/45kg and has a 64-day meat withdrawal period.
Massimo (pictured left) qualified from Bologna Vet School in 1990 and spent two decades working as a specialist in veterinary neurology in Italy and Germany, following a three-year residency in neurology and neurosurgery at Bern in Switzerland.He has also spent almost 20 years lecturing at universities in Italy, including ten years as head of neurosurgery and advanced neurology diagnostics.
He said: "During my career I’ve spent short amounts of time in the UK and once I was aware of the opportunity to work with Northwest Veterinary Specialists, I jumped at the chance to move here.
"It has a fantastic reputation in providing the very best care to pets, and the recent investment in state-of-the-art facilities means we can offer the very best service to patients.
"I have a particular interest in continually improving our work around brain and spinal surgery and biopsies, and will be further researching technology and techniques to support treatment of epilepsy in pets."
Luca, who is currently a member of the Examinations Committee of the European College of Veterinary Neurology, also qualified in Italy (in 2007) at the University of Perugia, before moving to England where he completed his internship program in small animal medicine & surgery in 2009. He gained residency at a multi disciplinary referral hospital in the UK and was awarded the European College of Veterinary Neurology (ECVN) in 2012.
Luca has authored scientific papers in peer reviewed international journals and he has also been a reviewer for the Journal of Small Animal Practice and for the BMC Veterinary Research.
He said: "We’ll be focusing on changing the way we do neurosurgery to ensure the pets referred to us receive the very best treatment for their condition.
"We often see patients with intervertebral disc disease and epilepsy, and I’m looking to increase work around my main interests, including surgery of the central nervous system and epilepsy."
Liz Cousins, hospital manager at Northwest Veterinary Specialists said: "This year we’ve been making significant investment in our facilities and people, so it’s fantastic to be able to attract two experienced neurology specialists in Luca and Massimo,” said Liz Cousins, hospital manager at Northwest Veterinary Specialists.
"Luca and Massimo’s appointments clearly demonstrate our emphasis on creating teams of experienced and extremely knowledgeable specialists across the centre."
The study, published in Nature Scientific Reports, investigated the effect of culling in the first three licensed badger cull areas – Gloucestershire, Somerset and Dorset – using data from 2013 to 2017.
Gloucestershire and Somerset saw reductions in bTB incidence rates in cull areas relative to comparison areas of 66 per cent and 37 per cent respectively after four years. In Dorset, there was no change in incidence rates in cull areas relative to comparison areas after two years, but incidence dropped by 55 per cent in the same period in the 2km buffer zone around the edge of the cull area. Matched comparison areas were similar but not identical.
James Russell, BVA Junior Vice President said: "These findings are encouraging and offer further evidence that badger culling can result in significant reductions in the number of new cases of TB in cattle. However, they come with the caveat that the data only relates to the first three cull areas, and the variability within these alone makes it too early to draw firm conclusions that culling will reduce incidence significantly in all 40 areas where it is now taking place.
"BVA’s expert working group is currently considering all aspects of disease control looking at cattle testing, removal of reactors, compensation and control in other farmed animals as well as the culling and vaccination of badgers. The group will consider this additional evidence as we develop our new policy on bTB.
"We continue to support a comprehensive and evidence-based approach to tackling bTB, including the use of badger culling where there is a demonstrated need and where it is done safely, humanely and effectively as part of a comprehensive strategy.
"The best way of halting the spread of this devastating disease is enhancing our understanding of bTB and applying that evidence to the eradication process.”
The company's new van has a range of 146 miles before it needs recharging, and it can be recharged to 80% within 40 minutes.
That puts 60% of MWI's customers within range of its distribution centre in Stoke-on-Trent, including those in Manchester and Birmingham.
As part of its drive to establish more sustainable operations, MWI has also launched a pilot with one of its corporate customers in which they reduce the number of deliveries made per week – adopting a two or three-day a week delivery system.
The company says that since January, that has resulted in 700,000 fewer vehicle miles.